DOT1L and primary cutaneous T-cell non-Hodgkin lymphoma: Taken together, although we could not find synergistic or suppressive effects of HDAC- and DOT1L-inhibitors in CTCL during short term in vitro cell culture, the crosstalk between HDAC and DOT1L still warrants further investigation, especially in the context of in vivo immune responses.